MOSCOW (MRC) -- Moody's views the proposal by Third Point Capital, who has reportedly taken a roughly 2.5% equity stake in The Dow Chemical Company (Dow), as being a credit negative, according to the Moody's statement.
However, Moody's does not believe that Dow will implement this proposal and instead will accelerate its planned cost reductions and divestitures, and undertake incremental increases to shareholder remuneration. Moderate increases to shareholder remuneration would not have a negative impact on Dow's rating or outlook.
As MRC wrote previously, in December 2013, Dow Chemical unveiled its plans to separate chlorine-related assets including its epoxy business as the company focuses on higher-margin activities. The chlorine assets account for as much as USD5 billion of annual revenue and include plants at 11 sites employing almost 2,000 people.
Earlier last year, Grace had completed the acquisition of the assets of the Polypropylene Licensing and Catalysts business of The Dow Chemical Company for a cash purchase price of USD500 mln. The acquisition includes UNIPOL Polypropylene Process Technology and makes Grace the second largest polypropylene licensor in the world based on installed capacity, advancing Grace's leadership in the broader polyolefin sector.
Third Point LLC is an SEC-registered investment adviser based in New York. The firm was founded in 1995 by Daniel S. Loeb, who serves as Chief Executive Officer. Third Point focuses on event-driven, value-oriented investing.
The Dow Chemical Company is an American multinational chemical corporation headquartered in Midland, Michigan, United States. It is also one of the largest chemical companies in the world, with annual revenues of over USD56 billion. Dow is a large producer of plastics, including polystyrene, polyurethane, polyethylene, polypropylene, and synthetic rubber.
MRC